Africa CDC appelle à une action immédiate pour protéger des vies face à l’escalade des crises sanitaires et sécuritaires
Addis Abeba, Éthiopie, 31 Janvier 2025 – L’Afrique est confrontée à une convergence sans précédent de crises menaçant d’anéantir des décennies de progrès en matière de sécurité sanitaire. Le nombre d’urgences sanitaires sur le continent a explosé, passant de 153 flambées épidémiques en 2022-2023 à 242 en 2024, augmentant ainsi le risque d’une nouvelle pandémie […]
Africa CDC Urges Immediate Action to Protect Lives Amid Escalating Health and Security Crises
Addis Ababa, Ethiopia, 31 January 2025 – Africa is facing an unprecedented convergence of crises that threaten to undo decades of progress in health security. The number of health emergencies in Africa surged from 153 outbreaks in 2022-2023 to 242 in 2024, raising the risk of another pandemic emerging from the continent. Meanwhile, a shifting global landscape has seen many […]
Tanzania Declares Marburg Outbreak: Africa CDC Mobilizes Immediate Response
ADDIS ABABA, January 20, 2025 – Tanzania has declared a Marburg virus disease (MVD) outbreak after confirming one case and identifying 25 suspected cases in the Kagera Region of Northwestern Tanzania. The Marburg virus, a highly infectious and often fatal disease, is similar to Ebola and is transmitted to humans from fruit bats and monkeys. […]
Enrollment Starts in Africa CDC-LED Mpox Therapeutic Study (MOSA)
ADDIS ABABA, KINSHASA, WASHINGTON, PARIS, January 15, 2025 – Africa CDC’s support for the MOSA, a pan-African randomized platform adaptive trial for the MpOx Study, adding to the initial EU funding, has enabled the enrollment of the first patients at Mbandaka Hospital in Equateur Province, Democratic Republic of Congo (DRC). These patients have been randomized […]
Africa CDC félicite l’Egypte pour avoir franchi une étape importante dans la réglementation des médicaments et des vaccins
The Africa CDC congratulates the Egyptian Drug Authority on its historic milestone of earning the WHO’s Maturity Level 3 (ML3) designation for medicines regulation.
Africa CDC Applauds Egypt’s Milestone Achievement in Medicines and Vaccine Regulation
The Africa CDC congratulates the Egyptian Drug Authority on its historic milestone of earning the WHO’s Maturity Level 3 (ML3) designation for medicines regulation.
GLOWACON Regional Conference Concludes with a Call to Advance Wastewater and Environmental Surveillance for Public Health in Africa
Addis Ababa, Ethiopia, 13 December – The Global Wastewater and Environmental Surveillance Consortium (GLOWACON) Regional Conference, held on 9th and 10th December under the auspices of the Africa Centres for Disease Control and Prevention (Africa CDC), the Health Emergency Preparedness and Response Authority (HERA), and the World Health Organization (WHO), convened over 250 participants from diverse […]
Huge Accolades for Dr Amadou Sall’s appointment as the Executive Director of Manufacturing and Supply Chain of the CEPI
Addis Ababa, Ethiopia, 9 December – The appointment of Dr Amadou Alpha Sall as CEPI’s Executive Director of Manufacturing and Supply Chain adds impetus to Africa’s ambition to break the unfair global health system that hinders access to vaccines. Dr Sall brings a wealth of scientific and leadership track records to CEPI from his first-hand […]
Déclaration d’Africa CDC sur l’obtention par les Autorités Nationales de Réglementation du Rwanda et du Sénégal du niveau de maturité 3 de l’OMS
Addis-Abeba, le 9 décembre 2024 – Les Centres africains de contrôle et de prévention des maladies (Africa CDC) félicitent chaleureusement les Autorités Nationales de Régulation (ANRs) du Rwanda (Food and Drugs Authority) et du Sénégal (Agence Sénégalaise de Réglementation Pharmaceutique) pour l’obtention du statut de Maturité Niveau 3 (ML3) reconnu par l’Organisation Mondiale de la […]
Statement from Africa CDC on Rwanda and Senegal National Regulatory Authorities Achieving WHO Maturity Level 3
Addis Ababa, 9 December 2024 – Africa CDC congratulates the Rwanda Food and Drug Regulatory Authority (Rwanda FDA) and the Senegalese Pharmaceutical Regulatory Agency (ARP) on achieving World Health Organization (WHO) Maturity Level 3 (ML3). This landmark achievement underscores Africa’s growing capacity to strengthen health systems through robust regulatory frameworks that ensure the quality, safety, […]